Cargando…

Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy

BACKGROUND AND PURPOSE: In locally advanced prostate cancer (PC), androgen deprivation therapy (ADT) in combination with whole prostate radiotherapy (RT) is the standard treatment. ADT affects the prostate as well as the tumour on multiparametric magnetic resonance imaging (MRI) with decreased PC co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Björeland, Ulrika, Nyholm, Tufve, Jonsson, Joakim, Skorpil, Mikael, Blomqvist, Lennart, Strandberg, Sara, Riklund, Katrine, Beckman, Lars, Thellenberg-Karlsson, Camilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058024/ https://www.ncbi.nlm.nih.gov/pubmed/33898790 http://dx.doi.org/10.1016/j.phro.2021.01.004

Ejemplares similares

Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT
por: Björeland, Ulrika, et al.
Publicado: (2018)

Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study
por: Björeland, Ulrika, et al.
Publicado: (2023)

The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography
por: Nilsson, Erik, et al.
Publicado: (2023)

Registration of histopathology to magnetic resonance imaging of prostate cancer
por: Sandgren, Kristina, et al.
Publicado: (2021)

Improved PET/MRI attenuation correction in the pelvic region using a statistical decomposition method on T2-weighted images
por: Wallstén, Elin, et al.
Publicado: (2020)

Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [(68)Ga]PSMA-11-PET and [(11)C]Acetate-PET
por: Sandgren, Kristina, et al.
Publicado: (2023)

Radiation dosimetry of [(68)Ga]PSMA-11 in low-risk prostate cancer patients
por: Sandgren, Kristina, et al.
Publicado: (2019)

Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions
por: Jonsson, Joakim H, et al.
Publicado: (2010)

(11)C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study
por: Strandberg, Sara, et al.
Publicado: (2014)

Registration accuracy for MR images of the prostate using a subvolume based registration protocol
por: Jonsson, Joakim H, et al.
Publicado: (2011)

Deep learning‐based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy
por: Jamtheim Gustafsson, Christian, et al.
Publicado: (2021)

Haralick texture features from apparent diffusion coefficient (ADC) MRI images depend on imaging and pre-processing parameters
por: Brynolfsson, Patrik, et al.
Publicado: (2017)

The rationale for MR-only treatment planning for external radiotherapy
por: Jonsson, Joakim, et al.
Publicado: (2019)

Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments
por: Nyholm, Tufve, et al.
Publicado: (2009)

Improving MR image quality with a multi-task model, using convolutional losses
por: Simkó, Attila, et al.
Publicado: (2023)

Accuracy of inverse treatment planning on substitute CT images derived from MR data for brain lesions
por: Jonsson, Joakim H, et al.
Publicado: (2015)

Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
por: Wikström, Pernilla, et al.
Publicado: (2022)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Accuracy in local staging of prostate cancer by adding a three-dimensional T2-weighted sequence with radial reconstructions in magnetic resonance imaging
por: Jäderling, Fredrik, et al.
Publicado: (2018)

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2019)

Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?
por: Eom, Keun-Yong, et al.
Publicado: (2014)

Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy
por: Blute, Michael L., et al.
Publicado: (2017)

Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy
por: Sun, Qi, et al.
Publicado: (2023)

What matters to you? – Free-text comments in a questionnaire from patients undergoing radiotherapy
por: Olausson, Kristina, et al.
Publicado: (2019)

Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer
por: Milecki, Piotr, et al.
Publicado: (2009)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Development and psychometric testing of an instrument to measure the patient’s experience of external radiotherapy: The Radiotherapy Experience Questionnaire (RTEQ)
por: Olausson, Kristina, et al.
Publicado: (2017)

A review of substitute CT generation for MRI-only radiation therapy
por: Edmund, Jens M., et al.
Publicado: (2017)

Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
por: Gongora, Magdalena, et al.
Publicado: (2022)

Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical (11)C-acetate PET/CT
por: Strandberg, Sara, et al.
Publicado: (2018)

Sensitivity analysis of different quality assurance methods for magnetic resonance imaging in radiotherapy
por: Adjeiwaah, Mary, et al.
Publicado: (2020)

Mapping prostatic microscopic anisotropy using linear and spherical b-tensor encoding: A preliminary study
por: Nilsson, Markus, et al.
Publicado: (2021)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2020)

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer
por: Wei, Yongbao, et al.
Publicado: (2023)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Androgen Deprivation Therapy Reversibly Increases Endothelium‐Dependent Vasodilation in Men With Prostate Cancer
por: Nguyen, Paul L., et al.
Publicado: (2015)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_md8ics9290llh9iefh70m4n9mc